DFS | ||||
---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||
HR | P value | HR | P value | |
Age ≤ 50 | 1.57(0.62–4.00) | 0.34 | ||
Premenopausal | 1.14(0.49–2.88) | 0.79 | ||
T(T3 + T4) | 4.37(1.39–13.69) | 0.01 | 1.49(0.31–7.11) | 0.62 |
LN(positive) | 7.40(2.77–19.82) | < 0.01 | 3.98(1.05–15.12) | 0.04 |
M(M1) | 12.48(2.62–59.44) | < 0.01 | 2.19(0.30–16.25) | 0.44 |
AJCC stage(III + IV) | 7.83(3.07–19.95) | < 0.01 | 2.30(0.61–8.69) | 0.22 |
Subtype(TN-MBC) | 0.60(0.20–1.83) | 0.37 | ||
Chemotherapy (yes) | 2.29(0.30–17.15) | 0.42 | ||
Radiotherapy (yes) | 2.38(0.88–6.45) | 0.88 | ||
Endocrine therapy (yes) | 0.95(0.13–7.18) | 0.96 | ||
Operation (BCS) | 0.55(0.13–2.40) | 0.43 | ||
Operation (SLNB) | 0.52(0.19–1.41) | 0.20 |